A149980 Stock Overview
Hironic Co., Ltd. provides aesthetic medical devices in South Korea and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||₩9,280.00|
|52 Week High||₩14,900.00|
|52 Week Low||₩4,535.00|
|1 Month Change||-22.67%|
|3 Month Change||-11.62%|
|1 Year Change||54.93%|
|3 Year Change||23.08%|
|5 Year Change||38.92%|
|Change since IPO||-36.70%|
Recent News & Updates
|A149980||KR Medical Equipment||KR Market|
Return vs Industry: A149980 exceeded the KR Medical Equipment industry which returned -6.2% over the past year.
Return vs Market: A149980 exceeded the KR Market which returned -15.8% over the past year.
|A149980 Average Weekly Movement||11.7%|
|Medical Equipment Industry Average Movement||5.8%|
|Market Average Movement||5.5%|
|10% most volatile stocks in KR Market||10.3%|
|10% least volatile stocks in KR Market||3.2%|
Stable Share Price: A149980 is more volatile than 90% of KR stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: A149980's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Hironic Co., Ltd. provides aesthetic medical devices in South Korea and internationally. It offers its products for the treatment of skin rejuvenation, face lifting, body shaping, acne, vaginal tightening, and hair transplantation and removal, as well as for the vascular and pigmented treatments. The company was founded in 2008 and is headquartered in Yongin-si, South Korea.
Hironic Fundamentals Summary
|A149980 fundamental statistics|
Is A149980 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A149980 income statement (TTM)|
|Cost of Revenue||₩8.63b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||549.26|
|Net Profit Margin||31.11%|
How did A149980 perform over the long term?See historical performance and comparison
0.5%Current Dividend Yield
Is Hironic undervalued compared to its fair value and its price relative to the market?
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: A149980 (₩9280) is trading above our estimate of fair value (₩1127.53)
Significantly Below Fair Value: A149980 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A149980 is poor value based on its PE Ratio (16.9x) compared to the KR Medical Equipment industry average (12.6x).
PE vs Market: A149980 is poor value based on its PE Ratio (16.9x) compared to the KR market (14.3x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate A149980's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A149980 is good value based on its PB Ratio (2x) compared to the KR Medical Equipment industry average (2.4x).
How is Hironic forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hironic has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Hironic performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A149980 has a high level of non-cash earnings.
Growing Profit Margin: A149980's current net profit margins (31.1%) are higher than last year (23.3%).
Past Earnings Growth Analysis
Earnings Trend: A149980's earnings have grown significantly by 45.7% per year over the past 5 years.
Accelerating Growth: A149980's earnings growth over the past year (124.3%) exceeds its 5-year average (45.7% per year).
Earnings vs Industry: A149980 earnings growth over the past year (124.3%) exceeded the Medical Equipment industry 30.5%.
Return on Equity
High ROE: A149980's Return on Equity (12.1%) is considered low.
How is Hironic's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A149980's short term assets (₩37.6B) exceed its short term liabilities (₩3.1B).
Long Term Liabilities: A149980's short term assets (₩37.6B) exceed its long term liabilities (₩4.6B).
Debt to Equity History and Analysis
Debt Level: A149980 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A149980's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A149980's debt is not well covered by operating cash flow (16.1%).
Interest Coverage: A149980 earns more interest than it pays, so coverage of interest payments is not a concern.
What is Hironic current dividend yield, its reliability and sustainability?
Dividend Score 1/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A149980's dividend (0.53%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (0.84%).
High Dividend: A149980's dividend (0.53%) is low compared to the top 25% of dividend payers in the KR market (2.73%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, A149980 has been paying a dividend for less than 10 years.
Growing Dividend: A149980's dividend payments have increased, but the company has only paid a dividend for 3 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (9%), A149980's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A149980 is paying a dividend but the company has no free cash flows.
How experienced are the management team and are they aligned to shareholders interests?
Hironic has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Hironic Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Hironic Co., Ltd.
- Ticker: A149980
- Exchange: KOSDAQ
- Founded: 2008
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: ₩113.506b
- Shares outstanding: 12.34m
- Website: https://www.hironic.com
Number of Employees
- Hironic Co., Ltd.
- 19th Floor
- South Korea
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/17 00:00|
|End of Day Share Price||2022/05/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.